Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cidara Therapeutics (CDTX) Insider Trading & Ownership

Cidara Therapeutics logo

Cidara Therapeutics (NASDAQ:CDTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.89%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$100.00M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$2.22M
Get CDTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cidara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDTX Insider Buying and Selling by Quarter

Cidara Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/10/2025Sell9,959$220.08$2,191,776.72  
9/11/2025Sell474$62.86$29,795.64  
6/26/2025
Ra Capital Management, L.P.
Director
Buy2,272,727$44.00$99,999,988.00  
(Data available from 1/1/2013 forward)

CDTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cidara Therapeutics includes Jeffrey Stein, Leslie Tari, Nicole Negar Davarpanah, Preetam Shah, Ra Capital Management, L.P., Shane Ward, and Taylor Sandison. Learn more on insiders at CDTX.

3.89% of Cidara Therapeutics stock is owned by insiders. Learn more on CDTX's insider holdings.

The following insiders have purchased CDTX shares in the last 24 months: Jeffrey Stein ($105,680.00), and Ra Capital Management, L.P. ($99,999,988.00).

Insiders have purchased a total of 2,280,727 CDTX shares in the last 24 months for a total of $100,105,668.00 bought.

The following insiders have sold CDTX shares in the last 24 months: Leslie Tari ($38,935.08), Nicole Negar Davarpanah ($29,795.64), Shane Ward ($2,228,318.16), and Taylor Sandison ($10,755.36).

Insiders have sold a total of 14,794 Cidara Therapeutics shares in the last 24 months for a total of $2,307,804.24 sold.



This page (NASDAQ:CDTX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners